Standout Papers

Antibiotic development — economic, regulatory and societal challenges 2019 2026 2021 2023 275
  1. Antibiotic development — economic, regulatory and societal challenges (2019)
    Christine Årdal, Manica Balasegaram et al. Nature Reviews Microbiology

Immediate Impact

3 by Nobel laureates 2 from Science/Nature 59 standout
Sub-graph 1 of 23

Citing Papers

Machine learning in point-of-care testing: innovations, challenges, and opportunities
2025 Standout
Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges
2025 Standout
2 intermediate papers

Works of David McAdams being referenced

Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective
2020
Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains ofNeisseria gonorrhoeae: a modelling study
2017

Author Peers

Author Last Decade Papers Cites
David McAdams 519 369 322 52 1.1k
Ajay Agrawal 110 237 31 40 1.2k
Robert A. Leitch 152 150 114 59 1.3k
Qian Liu 461 158 831 40 1.4k
Jennifer Brown 146 437 173 47 1.4k
Fei Wu 111 406 34 78 1.2k
Fernando García 319 186 89 70 1.0k
Mireia Jofre‐Bonet 81 346 57 60 1.0k
Mohammad Alamgir Hossain 71 67 182 56 1.2k
Hao Li 79 172 23 84 1.2k
David Johnstone 191 281 34 90 1.4k

All Works

Loading papers...

Rankless by CCL
2026